RVNC   $5.3  2.32% Market Closed After Close 5.29 -0.19%

Revance Therapeutics Inc

EMA (20): 2024-09-16 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-09-25 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (100): 2024-08-12 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: signal line crossed the middle level.

Trend Type turning up
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -11.54%
EMA (20) date of signal Sept. 16, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -0.38%
EMA (50) date of signal Sept. 25, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield -19.67%
EMA (100) date of signal Aug. 12, 2024, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Oct. 18, 2024, 3 a.m.
MACD Signals bearish weakening
MACD Yield 1.73%
MACD date of signal Oct. 15, 2024, 3 a.m.
Stochastic Signals bullish
Stochastic Yield 2.12%
Stochastic date of signal Oct. 17, 2024, 3 a.m.
Updated Oct. 20, 2024, 11:03 p.m.